Target intelligence / Profile preview

SPEM family member 2 (SPEM2)

Target
SPEM2
Molecular classification
Other (testis-enriched, not a receptor, enzyme, transporter, or transcription factor)
01

Overview

SPEM family member 2 (SPEM2) is a testis-enriched, 57 kDa protein encoded by the SPEM2 (C17orf74) gene on human chromosome 17p13.1[1][2][3]. SPEM2 is highly conserved across mammals and is predominantly expressed in post-meiotic male germ cells, where it is essential for spermiogenesis and normal sperm maturation[1]. Mouse knockout models lacking Spem2 display male infertility due to multiple spermiogenic defects, including abnormal acrosome formation, excessive cytoplasm retention, reduced sperm motility, and failed sperm-oocyte fusion[1]. SPEM2 localizes to the Golgi apparatus and interacts with proteins critical for acrosome development and sperm function (ZPBP, PRSS21, PRSS54, PRSS55, ADAM2, ADAM3), acting as a scaffold for their processing and maturation[1]. There is no evidence that SPEM2 is a classical therapeutic target such as a receptor, enzyme, transporter, or transcription factor. Its clinical relevance may primarily be in male infertility research[1][2][3].

Other names
C17orf74Chromosome 17 open reading frame 74Uncharacterized protein SPEM2SPEM2
02

Mechanism of action

Not a therapeutic target; no drugs act directly on SPEM2

03

Biological functions

Spermiogenesis (formation and maturation of spermatozoa)Fertilization (required for male fertility, especially sperm-oocyte fusion)Cytoplasm removal during spermiogenesisRegulation of protein processing and maturation in sperm (acts as a scaffold protein, not an enzyme)
04

Disease associations

Male infertility (loss of function leads to infertility in animal models; suggestive for human male infertility)
05

Safety considerations

No drug safety concerns or therapeutic challenges directly reported; knockout models exhibit male-specific infertility but no systemic safety signals

Beyond the preview

Go deeper on SPEM family member 2 (SPEM2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SPEM family member 2 (SPEM2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call